ABSTRACT Introduction Etrasimod is an oral sphingosine-1-phosphate receptor modulator approved for the treatment of moderate to severe ulcerative colitis. Its targeted mechanism, once-daily dosing, and oral formulation make it an important addition to the therapeutic landscape. However, its safety profile and optimal clinical positioning require careful evaluation.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Michael Colwill
Digital twins in IBD-bridging data, biology and trial innovation
Contributors MC: writing—original draft preparation, writing—review and editing. SH: writing—review and editing and supervision. AY: writing—review and editing. FM: writing—review and editing. VJ: writing—review and editing. SD: writing—review and editing. LPB: conceptualisation, writing—review and editing and supervision. All authors approved the final version of the manuscript and act as guarantors.
Clinical and Psychosocial Burden of Inflammatory Bowel Disease Among Transgender Individuals: A National BioResource Cohort Study
Back to Journals » Clinical and Experimental Gastroenterology » Volume 19 Authors Colwill M , Pollok R, Radia C, Seal LJ , Poullis A Received 16 June 2026 Accepted for publication 21 August 2026 Published 2 October 2026 Volume 2026:19 633494 DOI https://doi.org/10.2147/CEG.S633494 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Santosh Shenoy Michael Colwill,1,2 Richard Pollok,1,2 Chandni Radia,1,3 Leighton J...
Optimising Monoclonal Antibody Therapies for Inflammatory Bowel Diseas
Back to Journals » Clinical and Experimental Gastroenterology » Volume 18 Authors Colwill M , Honap S, Danese S, Peyrin-Biroulet L Received 9 June 2025 Accepted for publication 1 September 2025 Published 30 September 2025 Volume 2025:18 Pages 233—249 DOI https://doi.org/10.2147/CEG.S521893 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Vipul Yagnik Michael Colwill,1,2 Sailish Honap,1,3 Silvio Danese,4...
Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease-From Bench to Bedside
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Landscape of anti-IL-23 therapy in inflammatory bowel disease: recent advances
X @jennie_clough, @SamanthaIBD Contributors MC, JC and SB: investigation; writing–original draft, review and editing. KP and LP-B: writing–review and editing, supervision. SH: conceptualisation, writing–review and editing, supervision. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Impact of gender identity in the inflammatory bowel disease population: an evidence review and practical steps for gastroenterologists
Impact of gender identity in the inflammatory bowel disease population: an evidence review and practical steps for gastroenterologists Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Impact of gender identity in the inflammatory bowel disease population: an evidence review and practical steps for gastroenterologists
Contributors AP and MC were involved in the conception. MC was responsible for the initial drafting. All authors were involved in reviewing and finalising the article. The authors have all made contributions to the writing of the manuscript. All authors have read and agreed upon the submitted version of this paper and bear responsibility for the content.
JAK inhibitors for inflammatory bowel disease: recent advances
Following the publication of ORAL SURVEILLANCE in early 2022, the JAKi class of drugs was placed under safety review by the Pharmacovigilance Risk Assessment Committee (PRAC), a branch of the European Medicines Agency (EMA).4 PRAC recommendations were issued in October 2022 and were endorsed and approved by the EMA’s European Commission in March 2023.4 The MHRA followed suit and issued a statement in April 2023.5 Box 1 outlines these recommendations, which apply to all JAKi indicated for...
JAK inhibitors for inflammatory bowel disease: recent advances
JAK inhibitors for inflammatory bowel disease: recent advances Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. View Full Text Read the full text or download the PDF: Read the full text or download the PDF:
Cardiopulmonary resuscitation on television: are we miseducating the public?
Background Out-of-hospital cardiac arrest survival rates in the UK are poor, and non-medically trained individuals have been identified to perform substandard cardiopulmonary resuscitation (CPR). Millions watch televised medical dramas and, for many, these comprise their only education on CPR. This study aims to investigate the quality of CPR portrayed on these programmes and whether this has an effect on public knowledge.
Cardiopulmonary resuscitation on television: are we miseducating the public?
Background Out-of-hospital cardiac arrest survival rates in the UK are poor, and non-medically trained individuals have been identified to perform substandard cardiopulmonary resuscitation (CPR). Millions watch televised medical dramas and, for many, these comprise their only education on CPR. This study aims to investigate the quality of CPR portrayed on these programmes and whether this has an effect on public knowledge.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Michael
Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack